FDA NDC Directory · JSON-LD · Markdown

Glycopyrrolate

NDC 25021-796 · HUMAN PRESCRIPTION DRUG · INJECTION, SOLUTION

Labeler / ManufacturerSagent Pharmaceuticals
Marketing categoryAbbreviated NDA (generic) · App ANDA210083
Dosage form / routeINJECTION, SOLUTION · INTRAMUSCULAR INTRAVENOUS
Active ingredientsGLYCOPYRROLATE (.2 mg/mL)
Marketing started20241015
Package count3

External sources

Source: openFDA. Public-domain (CC0).